Article By:
Jim Van Meerten
Saturday, April 6, 2024 7:49 PM EDT
Atossa Therapeutics, a biopharmaceutical company focused on developing medicines in oncology, has a lead program in Phase II clinical trials for breast cancer, and 100% technical buy signals
In this article: ATOS